|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/18 | (2006.01) |
| A61K 31/496 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61K 31/551 | (2006.01) | ||
| A61K 31/546 | (2006.01) | ||
| A61K 31/407 | (2006.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61K 31/427 | (2006.01) | ||
| A61K 31/431 | (2006.01) | ||
| A61K 31/4545 | (2006.01) |
| (11) | Number of the document | 3519419 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17791737.4 |
| Date of filing the European patent application | 2017-09-28 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
| (46) | Date of publication of the claims translation | 2020-09-10 |
| (86) | Number | PCT/IB2017/055973 |
| Date | 2017-09-28 |
| (87) | Number | WO 2018/060926 |
| Date | 2018-04-05 |
| (30) | Number | Date | Country code |
| 201662401022 P | 2016-09-28 | US |
| (72) |
CASAREZ, Anthony, US
FUREGATI, Markus, CH
KOCH, Guido, CH
LIN, Xiaodong, US
OSSOLA, Flavio, CH
RECK, Folkert, US
SIMMONS, Robert Lowell, US
ZHU, Qingming, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Beta laktamazės inhibitoriai |
| BETA-LACTAMASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2021-08-20 | 5 | 115.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-09-28 |